Aktie A3EY43 NOVO INTEGRATED SCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Novo Integrated Sciences, Inc.

Aktien

A3EY43

US67011T3005

NVOS

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:01 03.05.2024 		% 5 Tage % 1. Jan.
0,523 USD -12,82 % Intraday Chart für Novo Integrated Sciences, Inc. +0,77 % -36,30 %
15.04. Novo Integrated Sciences, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 29. Februar 2024 CI
16.02. Novo Integrated Sciences, Inc. kündigt Änderungen in der Geschäftsführung an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Earnings Flash (NVOS) NOVO INTEGRATED SCIENCES Reports Q2 Revenue $3.2M
Novo Integrated Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
Novo Integrated Sciences : Private Placement - Form 8-K
Novo Integrated Sciences, Inc. announced that it has received $5.5 million in funding from Streeterville Capital, LLC
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
Novo Integrated Sciences Appoints New President
Novo Integrated Sciences, Inc. Announces Executive Changes
Earnings Flash (NVOS) NOVO INTEGRATED SCIENCES Posts Q1 Revenue $3.9M
Novo Integrated Sciences, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
Novo Integrated Sciences, Inc. Reports Earnings Results for the Full Year Ended August 31, 2023
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
Novo Integrated Sciences, Inc. Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
Sector Update: Health Care Stocks Rise Late Afternoon
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EY43 Aktie
  4. Nachrichten Novo Integrated Sciences, Inc.
  5. Andere Sprachen